SKI Market

A+| A| A-|

Indian Indices

Sensex

72,696.39 -1,836.57
( -2.46%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

51,583.72 -1,788.81
(-3.35%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

38.8

766.31

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.23

Back

ashok leyl& ltd

Anmol India standalone net profit rises 673.68% in the December 2025 quarter

Feb 12,2026

Net profit of Anmol India rose 673.68% to Rs 2.94 crore in the quarter ended December 2025 as against Rs 0.38 crore during the previous quarter ended December 2024. Sales rose 19.67% to Rs 303.16 crore in the quarter ended December 2025 as against Rs 253.32 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	303.16	253.32	20
OPM %	1.70	0.88	-
PBDT	4.11	0.61	574
PBT	3.93	0.51	671
NP	2.94	0.38	674

72,696.39 -1,836.57 ( -2.46%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

51,583.72 -1,788.81 (-3.35%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)